Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries
NCT01503567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 282
Last updated 2017-01-18
Summary
This study is conducted in Africa and Asia. The aim of this study is to evaluate in the participating countries the orthopaedic status and the degree of arthropathy of severe haemophilia patients in general.
Conditions
- Congenital Bleeding Disorder
- Haemophilia A
- Haemophilia A With Inhibitors
- Haemophilia B
- Haemophilia B With Inhibitors
Interventions
- OTHER
-
No treatment given
Subject will only fill out a questionaire
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- India
- Morocco
- Oman
- South Africa
Study Locations
More Related Trials
-
An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct
NCT05621746 ·Status: RECRUITING
-
Combining Registry Data in Haemophilia: TARGET H
NCT03264014 ·Status: COMPLETED
-
A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care
NCT02049099 ·Status: COMPLETED
-
2-cohort Study of Adult Patients With Severe Hemophilia A in Greece
NCT02319070 ·Status: COMPLETED
-
Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.
NCT03054662 ·Status: COMPLETED ·Phase: NA
-
Observational Study of Long-Term Joint Health Outcome in Hemophilia Patient
NCT04618237 ·Status: UNKNOWN
-
Survey Evaluating the Psychosocial Effects of Living With Haemophilia
NCT01322620 ·Status: COMPLETED
-
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors
NCT06312475 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
NCT02396862 ·Status: COMPLETED
-
TFPI Levels in Haemophilia A and B Patients
NCT04570696 ·Status: UNKNOWN
-
Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A
NCT02035384 ·Status: COMPLETED
-
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
NCT02453542 ·Status: RECRUITING
-
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
NCT06940830 ·Status: RECRUITING ·Phase: PHASE4
-
Sonography and Haemophilia
NCT04550988 ·Status: UNKNOWN
-
Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients
NCT04396639 ·Status: COMPLETED ·Phase: PHASE4
-
Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®
NCT04334057 ·Status: COMPLETED
-
Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
NCT00927667 ·Status: COMPLETED ·Phase: PHASE4
-
Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice
NCT01579955 ·Status: COMPLETED
-
Project to Update the Study of Congenital Haemophilia in Spain
NCT01959555 ·Status: COMPLETED
-
Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B
NCT03276130 ·Status: COMPLETED
-
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
NCT01988532 ·Status: COMPLETED
-
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis
NCT04583930 ·Status: UNKNOWN
-
Quality of Life Study of Helixate NexGen
NCT01053715 ·Status: COMPLETED
-
Data Registry in Chinese Hemophilia A and B Patients
NCT07101224 ·Status: COMPLETED
-
Multidisciplinary Evaluation of Patients With Hemophilia
NCT02198430 ·Status: COMPLETED